EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische Studie

Bisphosphonate drug holidays in osteoporosis according to fracture risk profile

Asunción Salmoral, P Peris, C López Medina, H Flórez, M Barceló, M Pascual Pastor, I Ros, D Grados, P Aguado, S García, L López, L Gifre und 11 weitere

Osteoporosis International · 2025

DOI: 10.1007/s00198-024-07309-9 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Osteoporosis International, 2025. Verfasst von Asunción Salmoral und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, University Hospital Reina Sofía, Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), University of Córdoba,…. Hauptthemen laut MEDLINE: Bone Density Conservation Agents, Osteoporotic Fractures, Diphosphonates, Osteoporosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Salmoral A..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Density Conservation AgentsOsteoporotic FracturesDiphosphonatesOsteoporosisHumansFemaleMaleRetrospective StudiesBone DensityAgedMiddle AgedSpinal FracturesAged, 80 and overDrug Administration ScheduleRisk FactorsBiomarkersBone RemodelingSpainRisk AssessmentWithholding TreatmentOsteoporosis, PostmenopausalIncidenceLumbar Vertebrae

Stichwörter der Autor:innen

BisphosphonateDrug holidaysFragility fractureHigh risk of fracture

Substanzen

Bone Density Conservation AgentsDiphosphonatesBiomarkers

Autor:innen und Institutionen

  • Department of Rheumatology, University Hospital Reina Sofía, Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), University of Córdoba, Cordoba, Spain. asuncionsalmoral61@gmail.com.
  • Department of Rheumatology, Hospital Clínic, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
  • Department of Rheumatology, University Hospital Reina Sofía, Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), University of Córdoba, Cordoba, Spain.
  • Department of Rheumatology, Rheumatology Research Group, Vall d'Hebron Research Institute, University Hospital Vall d´Hebron of Barcelona, Barcelona, Spain.
  • Department of Rheumatology, University Hospital Son Llàtzer, Palma de Mallorca, Spain.
  • Department of Rheumatology, University Hospital d' Igualada, Barcelona, Spain.

Förderung

  • Salmoral A.

Zitieren

APA

Salmoral, A., Peris, P., López Medina, C., Flórez, H., Barceló, M., Pascual Pastor, M., Ros, I., Grados, D., Aguado, P., García, S., López, L., Gifre, L., Cerdá, D., Aguilar, F. J., Panero, B., Costa, E., Casado, E., Hernández, B., Martínez Ferrer, A., …, & OsteoResSer Working Group of the Spanish Society of Rheumatology (2025). Bisphosphonate drug holidays in osteoporosis according to fracture risk profile. Osteoporosis International. https://doi.org/10.1007/s00198-024-07309-9

Vancouver

Salmoral A, Peris P, López Medina C, Flórez H, Barceló M, Pascual Pastor M, et al. Bisphosphonate drug holidays in osteoporosis according to fracture risk profile. Osteoporosis International. 2025. doi:10.1007/s00198-024-07309-9

BibTeX
@article{Salmoral2025,
  author = {Salmoral, Asunción and Peris, P and López Medina, C and Flórez, H and Barceló, M and Pascual Pastor, M and Ros, I and Grados, D and Aguado, P and García, S and López, L and Gifre, L and Cerdá, D and Aguilar, F J and Panero, B and Costa, E and Casado, E and Hernández, B and Martínez Ferrer, A and Graña, J and Gómez, I and Guañabens, N and OsteoResSer Working Group of the Spanish Society of Rheumatology, OsteoResSer Working Group of the Spanish Society of Rheumatology},
  title = {Bisphosphonate drug holidays in osteoporosis according to fracture risk profile},
  journal = {Osteoporosis International},
  year = {2025},
  doi = {10.1007/s00198-024-07309-9}
}
Kostenlos starten →